Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Ralpha) for alopecia areata patients. Maher E, Martiniuk F, Levis W. Allergy 2022;77:1073-1074.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maher E, Martiniuk F, Levis W. Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Ralpha) for alopecia areata patients. Allergy 2022;77:1073-1074.
PMID: 35218045